<?xml version="1.0" encoding="UTF-8"?>
<p>In conclusion, hydrogel-based MIPs are capable of specifically neutralizing virus infectivity 
 <italic>in vitro</italic> within a short enough incubation time to be clinically relevant. The findings of this study support the further evaluation of MIPs as alternative, stable, and economical “plastic” antibodies that could be used to treat and prevent viral infections.
</p>
